Last updated 2 months ago
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
612 patients around the world
Available in Spain, United States, Argentina
Abivax S.A.
4Research sites
612Patients around the world
This study is for people with
Ulcerative colitis
Moderate/severe ulcerative colitis
Requirements for the patient
From 16 Years
All Gender
Medical requirements
Sites
Instituto de Investigaciones Clínicas Quilmes
Recruiting
STAT Research - CABA
Recruiting
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Recruiting
Hospital Privado de Córdoba
SponsorAbivax S.A.
Conditions
Moderate/severe ulcerative colitis
Requirements
From 16 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05507203
